Is there a blood test that can diagnose Alzheimer's? Amy House helps you understand the hallmarks of Alzheimer's in the brain, new testing that can help diagnose Alzheimer's and new treatments that are available today.

Amy House, C.D.P. guides care partners in understanding how dementia affects the brain. This podcast has recorded questions from listeners. Each episode, Amy unpacks their questions and helps you learn to “think dementia.” This leads to better quality of life, improved relationships, and empowered care partners. Be part of a connected community by learning from each other’s questions.

Please consider supporting the Think Dementia podcast with a one-time or monthly donation at Buzzsprout Support Link Buzzsprout is the official podcast platform for Think Dementia and Amy pays to use this platform and distribute the podcast.

Rate us on Google Businesses: Think Dementia St. Paul MN on Google

To record a question for the podcast go to www.think-dementia.com/podcast

Amy House is a Certified Dementia Practitioner, Licensed Assisted Living Director and PAC Trainer who is recognized in the Twin Cities as a leader in dementia care and education. Amy's personal support, public speaking, and professional training has touched the lives of thousands of people living with dementia over the past 10 years. Amy is also a support group facilitator for the Alzheimer's Association and a Care Navigator for Tembo Health with the Medicare GUIDE dementia program.

Www.think-dementia.com

U of M Caregiving For People With Memory Loss Conference

U of M Caregiving for People with Memory Loss Conference Virtual Library

Think Dementia Podcast Episode: Do I Have To Keep All These Specialist Appointments?

Alzheimer's Clinical Trials

Alzheimer's Association Clinical Trials

Alzheimer’s Blood Test Detects Early Stages of Disease

https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/in-depth/alzheimers-treatments/art-20047780

Kinsula

Breakthrough In Alzheimer's Treatment Using Non-Invasive Ultrasound

Large Disparities In Adoption of New Alzheimer's Infusion Therapies Raise Concerns About Access

Early Alzheimer's Patients Continue to Benefit With Four Years Leqembi

Real‐world experience with lecanemab therapy for Alzheimer's disease in the Intermountain West

Amyloid Lurks in a Third of Cognitively Normal People Over the Age of 70

Support the show